Weifeng Tang

15PUBLICATIONS

46CO-AUTHORS

AutoimmunityPharmacogenomicsStatistical and quantitative geneticsComputational physiologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (15)

Sort by Publication Date:

|May 23, 2026

Anifrolumab Dose Regimen Selection for a Phase 3 Trial in Lupus Nephritis.

|Apr 14, 2026

Is a Clinical Trial With a Non-Bioequivalent Batch Necessary? The Critical Role of Intrasubject Variability in Olaparib Formulation Bridging by PBPK.

Jin Dong, Andrea Moir, Xavier Pepin

|Feb 04, 2026

Stochastic Gates for Covariate Selection in Population Pharmacokinetics Modeling.

Marija Kekic, Oleg Stepanov, Wenjuan Wang

|Dec 23, 2025

Minor Contribution of UGT1A1 Inhibition to Atazanavir-Related Bilirubin Elevation Supported by Conservative PBPK Modeling and Clinical Data.

Jin Dong, Pradeep Sharma, Rasha Emara

|May 14, 2025

An Integrative Mechanistic Model of Type 1 IFN-Mediated Inflammation in Systemic Lupus Erythematosus.

Alina Volkova, Victor Sokolov, Florencia Tettamanti

|Dec 14, 2024

Inhibition of OATP1B1/3 Rather Than UGT1A1 May Be the Major Cause of the Bilirubin Elevation After Atazanavir Administration.

Jin Dong, Pradeep Sharma, Rasha Emara

Pageof 3

Frequent Collaborators

David W Boulton

Victor Sokolov

Joanna Parkinson

Robert C Penland

Diansong Zhou

Jin Dong

Tatiana Yakovleva

Pradeep Sharma

Mats Någård

Raj Tummala

Frequent Collaborators

David W Boulton

Victor Sokolov

Joanna Parkinson

Robert C Penland